Dokumente
Suchschritt : FT=glucosamine AND FT=osteoarthritis
» Fenster schließen »

2/252 von 416 DIMDI: MEDLINE (ME60) © NLM

ND: | ME11567542
PMID: | 11567542
LR: | 20051116
CED: | 20010924
DCO: | 20011205
Autoren: | Häuselmann HJ
Titel: | Nutripharmaceuticals for osteoarthritis.
Quelle: | Best practice & research. Clinical rheumatology; VOL: 15 (4); p. 595-607 /200110/
PM: | Print
SU: | IM
Sprache: | English
CY: | England
JID: | 101121149
ISSN: | 1521-6942
Institution: | Centre for Rheumatology and Bone Disease, Klinik Im Park, Bellariastr.38, CH 8038, Switzerland.
DT: | Journal Article; Review
RN: | 45
Schlagwörter
CT: | CHONDROITIN SULFATES/therapeutic use; DIETARY SUPPLEMENTS/*; DRUG COMBINATIONS; DRUGS, NON-PRESCRIPTION/*therapeutic use; GLUCOSAMINE/therapeutic use; HUMANS; META-ANALYSIS; OSTEOARTHRITIS, HIP/*rehabilitation; OSTEOARTHRITIS, KNEE/*rehabilitation; PERSEA; PLANT EXTRACTS/therapeutic use; PLANTS, MEDICINAL; SOYBEANS; TRACE ELEMENTS/therapeutic use; TREATMENT OUTCOME; VITAMINS/therapeutic use
CTG: | CHONDROITINSULFATE/therapeutische Anwendung; NAHRUNGSERGÄNZUNGSMITTEL/*; ARZNEIMITTELKOMBINATIONSPRÄPARATE; ARZNEIMITTEL, NICHT VERSCHREIBUNGSPFLICHTIGE/*therapeutische Anwendung; GLUCOSAMIN/therapeutische Anwendung; MENSCH; METAANALYSE; OSTEOARTHROSE, HÜFT-/*Rehabilitation; OSTEOARTHROSE, KNIE/*Rehabilitation; PERSEA; PFLANZENEXTRAKTE/therapeutische Anwendung; PFLANZEN, ARZNEI-; SOJABOHNEN; SPURENELEMENTE/therapeutische Anwendung; BEHANDLUNGSERGEBNIS; VITAMINE/therapeutische Anwendung
TE: | Drug Combinations; Drugs, Non-Prescription; Plant Extracts; Trace Elements; Vitamins; Glucosamine/3416-24-8; Chondroitin Sulfates/9007-28-7
CR: | 3416-24-8; 9007-28-7
AB: | What is the level of evidence for current symptomatic agents (SYSADOA) in patients with osteoarthritis? Existing publications which met the inclusion criteria were rated by calculating the effect size of the compounds and applying a quality assessment score of the study methodology. This produced a median effect size for the primary outcome measure, pain, of 1.37 (range 0.37-1.50) for chondroitin-sulphate and 0.57 (range 0.26-1.02) for glucosamine-sulphate in patients with knee osteoarthritis. These effect sizes were strongly diminished when only recent high-quality studies were considered (effect size of pain for chondroitin-sulphate 0.37 and for glucosamine-sulphate 0.26). Effect sizes for functional improvement and overall WOMAC index (pain, stiffness and function) were in the same range for both compounds. So far, and in contrast to recent claims, there is no reliable scientific evidence that these two substances have structure-modifying actions with respect to prohibiting, healing or restoring cartilage lesions. There is only scarce or no scientific evidence for the effects of nutrients in patients with knee, hip or hand osteoarthritis. Several large company-sponsored and independent trials with several of these nutripharmaceuticals are ongoing in Europe and the USA. - CNOTE: Copyright 2001 Harcourt Publishers Ltd.

» Volltext »
» Fenster schließen »